Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma

Cancer

Volumn 119, Issue 21, 2013, Pages 3812-3820

  Peng, Zhen Wei ^a   Liu, Fu Rong ^a   Ye, Sheng ^a   Xu, Li ^b   Zhang, Yao Jun ^b   Liang, Hui Hong ^b   Lin, Xiao Jun ^b   Lau, Wan Yee ^c   Chen, Min Shan ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

elderly patients; hepatocellular carcinoma; liver; prognosis; radiofrequency ablation; resection

Indexed keywords

AGED; ARTICLE; CANCER PROGNOSIS; CANCER SIZE; CANCER SURVIVAL; CHINA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EARLY CANCER; ELDERLY CARE; ELECTRODE; FEMALE; GENERATOR; GERIATRIC PATIENT; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PUMP; RADIOFREQUENCY ABLATION; RADIOFREQUENCY ABLATION DEVICE; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SYRINGE PUMP; ULTRASOUND TRANSDUCER;

ELDERLY PATIENTS; HEPATOCELLULAR CARCINOMA; LIVER; PROGNOSIS; RADIOFREQUENCY ABLATION; RESECTION;

AGE OF ONSET; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE PROGRESSION; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84886085552     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28293     Document Type: Article

References (38)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D,. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Chen JG, Zhang SW,. Liver cancer epidemic in China: Past, present and future. Semin Cancer Biol. 2011; 21: 59-69.
3. Cao KJ, Fan QY, Liu YL, et al. Cancer incidence and mortality in Guangzhou City from 2000 to 2002 [in Chinese]. Chinese J Cancer. 2008; 27: 225-230.
4. O'Leary JG, Lepe R, Davis GL,. Indications for liver transplantation. Gastroenterology. 2008; 134: 1764-1776.
5. Adam R, Hoti E,. Liver transplantation: the current situation. Semin Liver Dis. 2009; 29: 3-18.
6. Peng ZW, Zhang YJ, Chen MS, et al. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. J Clin Oncol. 2013; 31: 426-432.
7. Nathan H, Bridges JF, Schulick RD, et al. Understanding surgical decision making in early hepatocellular carcinoma. J Clin Oncol. 2011; 29: 619-625.
8. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006; 243: 321-328.
9. Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010; 252: 903-912.
10. Ge YS, Xu GL, Zhang CH, et al. Efficacy and feasibility of radiofrequency ablation for hepatocellular carcinoma patients. Hepatogastroenterology. 2012; 59: 2540-2542.
11. Lau WY, Lai EC,. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009; 249: 20-25.
12. Chen MS, Peng ZW, Xu L, Zhang YJ, Liang HH, Li JQ,. Role of radiofrequency ablation in the treatment of hepatocellular carcinoma: experience of a cancer center in China. Oncology. 2011; 81 (suppl 1): 100-104.
13. N'Kontchou G, Mahamoudi A, Aout M, et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology. 2009; 50: 1475-1483.
14. Lee SH, Choi HC, Jeong SH, et al. Hepatocellular carcinoma in older adults: clinical features, treatments, and survival. J Am Geriatr Soc. 2011; 59: 241-250.
15. Künzli BM, Abitabile P, Maurer CA,. Radiofrequency ablation of liver tumors: Actual limitations and potential solutions in the future. World J Hepatol. 2011; 3: 8-14.
16. Nishikawa H, Osaki Y, Iguchi E, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma: clinical outcome and safety in elderly patients. J Gastrointestin Liver Dis. 2012; 21: 397-405.
17. Oishi K, Itamoto T, Kobayashi T, et al. Hepatectomy for hepatocellular carcinoma in elderly patients aged 75 years or more. J Gastrointest Surg. 2009; 13: 695-701.
18. Nanashima A, Abo T, Nonaka T, et al. Prognosis of patients with hepatocellular carcinoma after hepatic resection: Are elderly patients suitable for surgery? J Surg Oncol. 2011; 104: 284-291.
19. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. European Association for the Study of the Liver. J Hepatol. 2001; 35: 421-430.
20. Liang HH, Chen MS, Peng ZW, et al. Percutaneous radiofrequency ablation versus repeat hepatectomy for recurrent hepatocellular carcinoma: a retrospective study. Ann Surg Oncol. 2008; 15: 3484-3493.
21. Catalano O, Esposito M, Nunziata A, Siani A,. Multiphase helical CT findings after percutaneous ablation procedures for hepatocellular carcinoma. Abdom Imaging. 2000; 25: 607-614.
22. Makuuchi M, Hasegawa H, Yamazaki S,. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet. 1985; 161: 346-350.
23. Sobin LH, Wittekind C,. TNM Classification of Malignant Tumours. 6th ed. Hoboken, NJ: John Wiley & Sons; 2002.
24. Bruix J, Sherman M,; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53: 1020-1022.
25. National Institutes of Health. National Cancer Institute Common Toxicity Criteria, Version 4.0: Cancer Therapy Evaluation Program, 2009. NIH Publication 09-5410. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference- 5x7.pdf. Revised June 2010.
26. Venook AP, Papandreou C, Furuse J, de Guevara LL,. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010; 15 (suppl 4): 5-13.
27. Sanyal AJ, Yoon SK, Lencioni R,. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010; 15 (suppl 4): 14-22.
28. Jansen PL,. Liver disease in the elderly. Best Pract Res Clin Gastroenterol. 2002; 16: 149-158.
29. Takahashi H, Mizuta T, Kawazoe S, et al. Efficacy and safety of radiofrequency ablation for elderly hepatocellular carcinoma patients. Hepatol Res. 2010; 40: 997-1005.
30. Huang J, Hernandez-Alejandro R, Croome KP, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases. J Gastrointest Surg. 2011; 15: 311-320.
31. Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol. 2008; 15: 1375-1382.
32. Rossi S, Ravetta V, Rosa L, et al. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology. 2011; 53: 136-147.
33. Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009; 249: 617-623.
34. Shiba H, Ishida Y, Wakiyama S, et al. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection. J Gastrointest Surg. 2009; 13: 1636-1642.
35. Napoletano C, Taurino F, Biffoni M, et al. RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol. 2008; 32: 481-490.
36. Bruix J, Sherman M,. Management of hepatocellular carcinoma. Hepatology. 2005; 42: 1208-1236.
37. Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in chrrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology. 2008; 47: 97-104.
38. Rimola J, Forner A, Tremosini S, et al. Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol. 2012; 56: 1317-1323.